{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-24-006534","form_type":"8-K","ticker":"ANVS","cik":"0001477845","company_name":"Annovis Bio, Inc.","filed_at":"2024-05-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.591284+00:00","generated_at":"2026-06-03T00:19:12.087315+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"low","headline":"Annovis Bio closes common stock purchase agreement with equity line investor","bullets":["Closed transactions contemplated by Common Stock Purchase Agreement entered April 25, 2024.","Equity line investor purchased shares; no specific dollar amount or share count disclosed.","Loeb & Loeb LLP opinion on securities issuance filed as Exhibit 5.1."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-24-006534","json":"https://secwatch.observer/filing/0001558370-24-006534.json","markdown":"https://secwatch.observer/filing/0001558370-24-006534.md","text":"https://secwatch.observer/filing/0001558370-24-006534.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1477845/000155837024006534/0001558370-24-006534-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1477845/000155837024006534/anvs-20240502x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T00:19:12.087315+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}